---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-009667"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2025-05-12T23:59:59+00:00"
generated_at: "2026-05-21T23:12:18.336256+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q1 revenue $7.5M (+9% YoY); recurring up 29%; operating loss widens to $5.9M

## Summary
- Revenue $7.5M (+9% YoY); system revenue $2.0M, recurring revenue $5.5M (+29% driven by Map-iT catheters).
- Operating loss ($5.9M) vs ($4.7M) prior year; net loss ($5.8M) vs ($4.5M). Adjusted operating loss ($2.7M).
- Cash $10.7M, no debt; free cash flow negative ($1.8M), improved from ($2.3M) YoY.
- Reiterates FY 2025 double-digit revenue growth; expects recurring revenue to scale to $7M in Q4.
- First GenesisX order received; initial MAGiC commercialization in Europe; six active regulatory reviews.

## SEC filing metadata
- accession: 0001641172-25-009667
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2025-05-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000164117225009667/0001641172-25-009667-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000164117225009667/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-009667
- JSON: https://secwatch.observer/filing/0001641172-25-009667.json
- Plain text: https://secwatch.observer/filing/0001641172-25-009667.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.